Drug Development

Apr 03, 2018
By Pharmaceutical Technology Editors
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
Apr 03, 2018
By Pharmaceutical Technology Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Apr 02, 2018
Pharmaceutical Technology
Research suggests that radiation can have a significant impact on the composition and rheology of hydroxyethyl cellulose-based medicinal gels.
Apr 02, 2018
Pharmaceutical Technology
Researchers at MIT have discovered a new set of compounds that do not elicit a foreign body response when implanted. These biomaterials permit the development of a new category of treatment with the ability to deliver therapeutics either at a constant rate or under programmable conditions by using implantable cells as protein factories.
Apr 02, 2018
Pharmaceutical Technology
Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Apr 02, 2018
Pharmaceutical Technology
The high viscosity of highly concentrated monoclonal antibody formulations not only presents processing and storage difficulties, but also formulation and delivery challenges.
Apr 02, 2018
By Pharmaceutical Technology Editors
Nik Leist’s keynote address will explore the manufacturing of digital medicines at the CPhI North America 2018 conference in Philadelphia, PA, on Wednesday, April 25, 2018.
native1_300x100
lorem ipsum